Chelu, Raluca G.
Horowitz, Michael
Sucha, Dominica
Kardys, Isabella
Ingremeau, Delphine
Vasanawala, Shreyas
Nieman, Koen
Paul, Jean-Francois
Hsiao, Albert
Funding for this research was provided by:
Hartstichting
GE Healthcare
Article History
Received: 7 March 2018
Revised: 10 August 2018
Accepted: 16 August 2018
First Online: 31 August 2018
Compliance with ethical standards
:
: R.G. Chelu received funding for research from GE Healthcare and is a consultant to Arterys, Inc. J.W. Roos-Hesellink received a grant from the Dutch Heart Foundation. K. Nieman reports non-financial support from Siemens Medical Solutions and grants from GE Healthcare and Bayer Healthcare, outside the submitted work. S.S. Vasanawala is involved in research collaboration with GE Healthcare, is founder of and consultant to Arterys, Inc., and received a research grant from Bayer AG. A. Hsiao is founder of and consultant to Arterys, Inc., and received a research grant from GE Healthcare. The rest of the authors report no conflict of interest.
: Patient studies were aggregated from multiple centers and approved by each local IRB, including either a waiver of consent or prospective enrollment with signed consent, as deemed appropriate by each center. The study protocol was compliant with the Declaration of Helsinki.